These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability. Halpern BS; Dahlbom M; Quon A; Schiepers C; Waldherr C; Silverman DH; Ratib O; Czernin J J Nucl Med; 2004 May; 45(5):797-801. PubMed ID: 15136629 [TBL] [Abstract][Full Text] [Related]
3. Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system. Strobel K; Rüdy M; Treyer V; Veit-Haibach P; Burger C; Hany TF Nucl Med Commun; 2007 Jul; 28(7):555-9. PubMed ID: 17538397 [TBL] [Abstract][Full Text] [Related]
4. Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging. Brechtel K; Klein M; Vogel M; Mueller M; Aschoff P; Beyer T; Eschmann SM; Bares R; Claussen CD; Pfannenberg AC J Nucl Med; 2006 Mar; 47(3):470-6. PubMed ID: 16513616 [TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer. Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965 [TBL] [Abstract][Full Text] [Related]
7. Two-dimensional vs three-dimensional imaging in whole body oncologic PET/CT: a Discovery-STE phantom and patient study. Bettinardi V; Mancosu P; Danna M; Giovacchini G; Landoni C; Picchio M; Gilardi MC; Savi A; Castiglioni I; Lecchi M; Fazio F Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):214-23. PubMed ID: 17464266 [TBL] [Abstract][Full Text] [Related]
8. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study. Iagaru A; Mittra E; Yaghoubi SS; Dick DW; Quon A; Goris ML; Gambhir SS J Nucl Med; 2009 Apr; 50(4):501-5. PubMed ID: 19289439 [TBL] [Abstract][Full Text] [Related]
9. F-18 FDG PET/CT in the management of thyroid cancer. Iagaru A; Kalinyak JE; McDougall IR Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020 [TBL] [Abstract][Full Text] [Related]
10. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer. Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572 [TBL] [Abstract][Full Text] [Related]
11. Optimizing injected dose in clinical PET by accurately modeling the counting-rate response functions specific to individual patient scans. Watson CC; Casey ME; Bendriem B; Carney JP; Townsend DW; Eberl S; Meikle S; Difilippo FP J Nucl Med; 2005 Nov; 46(11):1825-34. PubMed ID: 16269596 [TBL] [Abstract][Full Text] [Related]
12. Investigation of 18F-FDG 3D mode PET image quality versus acquisition time. Brown C; Dempsey MF; Gillen G; Elliott AT Nucl Med Commun; 2010 Mar; 31(3):254-9. PubMed ID: 20032801 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of a breath-holding acquisition method in PET/CT for pulmonary lesions. Yamaguchi T; Ueda O; Hara H; Sakai H; Kida T; Suzuki K; Adachi S; Ishii K Ann Nucl Med; 2009 Jan; 23(1):65-71. PubMed ID: 19205840 [TBL] [Abstract][Full Text] [Related]
14. Attenuation correction of PET images with respiration-averaged CT images in PET/CT. Pan T; Mawlawi O; Nehmeh SA; Erdi YE; Luo D; Liu HH; Castillo R; Mohan R; Liao Z; Macapinlac HA J Nucl Med; 2005 Sep; 46(9):1481-7. PubMed ID: 16157531 [TBL] [Abstract][Full Text] [Related]
15. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin. Zhang M; Jiang X; Zhang M; Xu H; Zhai G; Li B J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438 [TBL] [Abstract][Full Text] [Related]
17. Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT. Dirisamer A; Schima W; Heinisch M; Weber M; Lehner HP; Haller J; Langsteger W Eur J Radiol; 2009 Mar; 69(3):536-41. PubMed ID: 18248928 [TBL] [Abstract][Full Text] [Related]
18. Optimization of the injected activity in dynamic 3D PET: a generalized approach using patient-specific NECs as demonstrated by a series of 15O-H2O scans. Walker MD; Matthews JC; Asselin MC; Saleem A; Dickinson C; Charnley N; Julyan PJ; Price PM; Jones T J Nucl Med; 2009 Sep; 50(9):1409-17. PubMed ID: 19690021 [TBL] [Abstract][Full Text] [Related]
19. Lesion concordance, image quality and artefacts in PET/CT: results of a multicenter study. Stergar H; Krause BJ; Eschmann SM; Juergens KU; Kuehl H; Pfannenberg AC; Stollfuss J; Weckesser M; Bockisch A Nuklearmedizin; 2010; 49(4):129-37. PubMed ID: 20514387 [TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]